Antibodies/Antisera
|
NR-2632
|
Polyclonal Anti-Vaccinia Virus (immune globulin G, Human)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-417
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-2), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-418
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-3), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-419
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-4), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-420
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-5), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-421
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-6), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-422
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-7)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-423
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-8), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-424
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-9), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-426
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-11), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-427
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-12), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-428
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-13), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-429
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-14), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-430
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-15), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-431
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-16), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-4546
|
Monoclonal Anti-Adenovirus E19, Clone TW1.3 (produced in vitro)
|
Adenovirus
|
BEI Level 1
|
|
NR-4547
|
Monoclonal Anti-Vaccinia Virus E3L, Clone TW2.3 (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-551
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-20), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-552
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-21), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-553
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-22), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-554
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-23), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-555
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-24), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-556
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-25), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-559
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-28), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-560
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-29), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-561
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-30), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-562
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-31), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-565
|
Monoclonal Anti-Vaccinia Virus (WR) A33R Protein, Residues 58 to 185 (similar to VMC-34), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-566
|
Monoclonal Anti-Vaccinia Virus (WR) L1R Protein, Residues 1 to 185 (similar to VMC-35), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-567
|
Monoclonal Anti-Vaccinia Virus (WR) A27L Protein, Residues 1 to 110 (similar to VMC-38), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-568
|
Monoclonal Anti-Vaccinia Virus (WR) A27L Protein, Residues 1 to 110 (similar to VMC-49), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-569
|
Monoclonal Anti-Vaccinia Virus (WR) A27L Protein, Residues 1 to 110 (similar to VMC-50), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-627
|
Polyclonal Anti-Vaccinia Virus (WR) A27L Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-628
|
Polyclonal Anti-Vaccinia Virus (WR) A33R Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-629
|
Polyclonal Anti-Vaccinia Virus (WR) B5R Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-630
|
Polyclonal Anti-Vaccinia Virus (WR) F9L Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-631
|
Polyclonal Anti-Vaccinia Virus (WR) L1R Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
Antibodies/Critical Reagents Program
Antigens/Critical Reagents Program
Assays/Panels
Cell Banks
Genomic Materials/Critical Reagents Program
Nucleic Acids
|
NR-2634
|
Genomic DNA from Vaccinia Virus, Modified Vaccinia Ankara (MVA)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2635
|
Genomic DNA from Vaccinia Virus, Lister (Elstree)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2636
|
Genomic DNA from Vaccinia Virus, IHD
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2637
|
Genomic DNA from Vaccinia Virus, Lederle-Chorioallantoic
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2638
|
Genomic DNA from Vaccinia Virus, New York City Board of Health (Wyeth, Calf adapted)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2639
|
Genomic DNA from Vaccinia Virus, Western Reserve (NIAID, Tissue culture adapted)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2640
|
Genomic DNA from Vaccinia Virus, Western Reserve (Mouse adapted)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2641
|
Genomic DNA from Cowpox Virus, Brighton Red
|
Cowpox virus
|
BEI Level 1
|
|
NR-3071
|
Genomic DNA from Monkeypox Virus, WRAIR 7-61
|
Monkeypox virus
|
BEI Level 1
|
|
NR-4076
|
Plasmid Containing Hemagglutinin Gene from Monkeypox Virus, Zaire 79, Linearized
|
Monkeypox virus
|
BEI Level 1
|
|
NR-4928
|
Genomic DNA from Monkeypox Virus, USA-2003
|
Monkeypox virus
|
BEI Level 1
|
|
NR-9343
|
Plasmid Containing a Segment of the E9L Gene from Vaccinia Virus, New York City Board of Health, Linearized
|
Orthopoxvirus
|
BEI Level 1
|
|
NR-9344
|
Pan-Ortho Pox E9L Gene-Specific Quantitative PCR Probe
|
Orthopoxvirus
|
BEI Level 1
|
|
NR-9345
|
Pan-Orthopox Virus E9L Gene-Specific Quantitative PCR Forward Primer
|
Orthopoxvirus
|
BEI Level 1
|
|
NR-9346
|
Pan-Orthopox Virus E9L Gene-Specific Quantitative PCR Reverse Primer
|
Orthopoxvirus
|
BEI Level 1
|
|
NR-9347
|
Monkeypox Virus Hemagglutinin Gene-Specific Quantitative PCR Probe
|
Monkeypox virus
|
BEI Level 1
|
|
NR-9348
|
Monkeypox Virus Hemagglutinin Gene-Specific Quantitative PCR Forward Primer
|
Monkeypox virus
|
BEI Level 1
|
|
NR-9349
|
Monkeypox Virus Hemagglutinin Gene-Specific Quantitative PCR Reverse Primer
|
Monkeypox virus
|
BEI Level 1
|
Proteins/Peptides
|
NR-10501
|
Variola Major Virus (Bangladesh-1975) M1R Protein, Recombinant from Baculovirus (Homolog of Vaccinia Virus L1R)
|
Variola major virus
|
BEI Level 1
|
|
NR-10502
|
Variola Major Virus (Bangladesh-1975) B6R Protein, Recombinant from Baculovirus (Homolog of Vaccinia Virus B5R)
|
Variola major virus
|
BEI Level 1
|
|
NR-10503
|
Variola Major Virus (India-1967) A36R Protein, Recombinant from Baculovirus (Homolog of Vaccinia Virus A33R)
|
Variola major virus
|
BEI Level 1
|
|
NR-2622
|
(WR) A27L Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2623
|
(WR) A33R Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2624
|
(WR) B5R Protein with N-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2625
|
(WR) L1R Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2626
|
(WR) F9L Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-4057
|
Peptide Arrays, HLA Supertype A and B Epitopes of Vaccinia Virus Proteins
|
Vaccinia virus
|
BEI Level 1
|
|
NR-4058
|
Peptide Arrays, H-2, Epitopes of Vaccinia Virus Proteins
|
Vaccinia virus
|
BEI Level 1
|
|
NR-545
|
(WR) A33R Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-546
|
(WR) B5R Protein with N-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
Viruses
|
NR-1
|
Vaccinia virus
|
Modified Vaccinia Ankara (MVA)
|
BEI Level 2
|
|
NR-15486
|
Guanarito Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Guanarito Virus, INH-95551 GPC Protein
|
BEI Level 2
|
|
NR-15487
|
Guanarito Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Guanarito Virus, INH-95551 L Protein
|
BEI Level 2
|
|
NR-15488
|
Guanarito Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Guanarito Virus, INH-95551 NP Protein
|
BEI Level 2
|
|
NR-15489
|
Guanarito Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Guanarito Virus, INH-95551 Z Protein
|
BEI Level 2
|
|
NR-15490
|
Junin virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Junin Virus, Candid #1 GPC Protein
|
BEI Level 2
|
|
NR-15491
|
Junin virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Junin Virus, XJ cl13 L Protein
|
BEI Level 2
|
|
NR-15492
|
Junin virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Junin Virus, Candid #1 NP Protein
|
BEI Level 2
|
|
NR-15494
|
Lassa virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Lassa Virus, Josiah L Protein
|
BEI Level 2
|
|
NR-15495
|
Lassa virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Lassa Virus, Josiah NP Protein
|
BEI Level 2
|
|
NR-15496
|
Lassa virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Lassa Virus, Josiah Z Protein
|
BEI Level 2
|
|
NR-15497
|
Lymphocytic choriomeningitis virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Lymphocytic choriomeningitis Virus, Armstrong 53b GPC Protein
|
BEI Level 2
|
|
NR-15498
|
Lymphocytic choriomeningitis virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Lymphocytic choriomeningitis Virus, Armstrong 53b L Protein
|
BEI Level 2
|
|
NR-15499
|
Lymphocytic choriomeningitis virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Lymphocytic choriomeningitis Virus, Armstrong 53b NP Protein
|
BEI Level 2
|
|
NR-15500
|
Lymphocytic choriomeningitis virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Lymphocytic choriomeningitis Virus, Armstrong 53b Z Protein
|
BEI Level 2
|
|
NR-15501
|
Machupo virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Machupo Virus, Carvallo GPC Protein
|
BEI Level 2
|
|
NR-15502
|
Machupo virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Machupo Virus, Carvallo L Protein
|
BEI Level 2
|
|
NR-15503
|
Machupo virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Machupo Virus, Carvallo NP Protein
|
BEI Level 2
|
|
NR-15504
|
Machupo virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Machupo Virus, Carvallo Z Protein
|
BEI Level 2
|
|
NR-15505
|
Sabia Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Sabiá Virus, SPH114202 GPC Protein
|
BEI Level 2
|
|
NR-15506
|
Sabia Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Sabiá Virus, SPH114202 NP Protein
|
BEI Level 2
|
|
NR-15507
|
Sabia Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Sabiá Virus, SPH114202 Z Protein
|
BEI Level 2
|
|
NR-15508
|
Whitewater Arroyo Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Whitewater Arroyo Virus, AV 9310135 GPC Protein
|
BEI Level 2
|
|
NR-15509
|
Whitewater Arroyo Virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Whitewater Arroyo Virus, AV 9310135 NP Protein
|
BEI Level 2
|
|
NR-15691
|
Junin virus
|
Vaccinia Virus, Wyeth, Recombinant Expressing Junin Virus, XJ GPC L Protein
|
BEI Level 2
|
|
NR-2324
|
Monkeypox virus
|
Zaire 79 (V79-I-005)
|
BEI Level 3
|
|
NR-2500
|
Monkeypox virus
|
USA-2003
|
BEI Level 3
|
|
NR-27
|
Monkeypox virus
|
WRAIR 7-61
|
BEI Level 3
|
|
NR-51
|
Vaccinia virus
|
Lister (Elstree)
|
BEI Level 2
|
|
NR-52
|
Vaccinia virus
|
IHD
|
BEI Level 2
|
|
NR-53
|
Vaccinia virus
|
Lederle-Chorioallantoic
|
BEI Level 2
|
|
NR-54
|
Vaccinia virus
|
New York City Board of Health (Wyeth, Calf adapted)
|
BEI Level 2
|
|
NR-55
|
Vaccinia virus
|
Western Reserve (NIAID, Tissue culture adapted)
|
BEI Level 2
|
|
NR-56
|
Vaccinia virus
|
Western Reserve (Mouse adapted)
|
BEI Level 2
|
|
NR-623
|
Vaccinia virus
|
MVA/S, Recombinant Expressing SARS CoV Spike (S) Protein
|
BEI Level 2
|
|
NR-624
|
Vaccinia virus
|
VV.NP-S-EGFP, Recombinant Expressing Enhanced Green Fluorescent Protein
|
BEI Level 2
|
|
NR-726
|
Vaccinia virus
|
Modified Vaccinia Ankara (MVA), From BHK-21 Cells
|
BEI Level 2
|
|
NR-727
|
Vaccinia virus
|
Modified Vaccinia Ankara (MVA), From BHK-21 Cells, Purified
|
BEI Level 2
|
|
NR-793
|
Vaccinia virus
|
vSC56, Recombinant Expressing Beta-Galactosidase
|
BEI Level 2
|
|
NR-88
|
Cowpox virus
|
Brighton Red
|
BEI Level 2
|
|
NR-9597
|
Cowpox virus
|
Brighton Red Recombinant Expressing Enhanced Green Fluorescent Protein
|
BEI Level 2
|
|